Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 69

Sort by

Sort Order Select

Journal Articles

Feasibility and Target AUC Accuracy of Personalized High Dose Melphalan in Myeloma

Blood (2024) 144 (Supplement 1): 1993.

https://doi.org/10.1182/blood-2024-205614

Published: 2024

Journal Articles

Haploidentical Peripheral Blood Stem Cell Transplantation in 20 Adult Patients with Sickle Cell Disease

Ekaterina Proskuriakova, Elisa Zucchetti, Karen Sweiss, Nadim Mahmud, Matthew Koshy, Damiano Rondelli, Santosh L. Saraf

Blood (2024) 144 (Supplement 1): 2101.

https://doi.org/10.1182/blood-2024-198407

Published: 2024

Journal Articles

VPA Expanded CD34+CD90+ Cells Despite Having Identical Phenotype Are Functionally Distinct Based on Their Origin

AL Rabee Kassis, Amudha Ganapathy, Amal Mechaal, Hawaa Khodor, Dolores Mahmud, Nadim Mahmud

Blood (2024) 144 (Supplement 1): 5617.

https://doi.org/10.1182/blood-2024-212061

Published: 2024

Journal Articles

Graft CD34+ Cell Dosing Adjustment Based on Body Surface Area As a Better Predictor of Hematopoietic Engraftment

Seungwon An, Youngmin Park, Celeste Mora, Chukwuemeka Uzoka, Matias Sanchez, Elisa Zucchetti, Karen Sweiss, Sally Campbell Lee, Damiano Rondelli, Nadim Mahmud

Blood (2024) 144 (Supplement 1): 7266.

https://doi.org/10.1182/blood-2024-210824

Published: 2024

Journal Articles

Retention of In Vivo Functional Potential of Cryopreserved Human HSPC Grafts after 10 Years

Youngmin Park, Dolores Mahmud, Grace Irene Charan, Amudha Ganapathy, AL Rabee Kassis, Elena Tepak, Damiano Rondelli, Nadim Mahmud

Blood (2024) 144 (Supplement 1): 7265.

https://doi.org/10.1182/blood-2024-212187

Published: 2024

Journal Articles

Addition of Myeloablative Doses of Total Marrow Irradiation (TMI) to Myeloablative Fludarabine/Busulfan Conditioning for Allogeneic HSCT in Patients with High-Risk AML, CML, or Myelodysplastic Syndrome: A Phase II Clinical Trial

Lucas Maahs, Matthew Koshy, Karen Sweiss, Kang-hyun Ahn, Zhengjia Chen, Chukwuemeka Uzoka, Carlos Galvez, Paul Rubinstein, John Quigley, Santosh L. Saraf, Ana Maria Avila Rodriguez, Bulent Aydogan, Nadim Mahmud, Damiano Rondelli

Blood (2023) 142 (Supplement 1): 4897.

https://doi.org/10.1182/blood-2023-179270

Published: 2023

Journal Articles

Long-Term Adverse Events of Total Marrow Irradiation (TMI)-Based Conditioning Chemotherapy in Hematopoietic Stem Cell Transplant Recipients Treated on a Phase I/II Trial

Lucas Maahs, Pritesh Patel, Karen Sweiss, Chukwuemeka Uzoka, Nadim Mahmud, Ana Maria Avila, Matthew Koshy, Damiano Rondelli

Blood (2022) 140 (Supplement 1): 12913–12914.

https://doi.org/10.1182/blood-2022-163424

Published: 2022

Journal Articles

Safety and Efficacy of the Addition of the Protein Translation Inhibitor Omacetaxine to Induction with Cytarabine and Idarubicin in Newly Diagnosed AML

Samin Houshyar, Betul Gok Yavuz, Pritesh Patel, Nadim Mahmud, Karen Sweiss, Irum Khan, Santosh L. Saraf, Damiano Rondelli, Anwar Khan, John G. Quigley

Blood (2022) 140 (Supplement 1): 5957–5958.

https://doi.org/10.1182/blood-2022-170100

Published: 2022

Journal Articles

G-CSF Improves Stable Engraftment in Adults with Sickle Cell Disease Undergoing Nonmyeloablative Hematopoietic Stem Cell Transplantation

Lucas Maahs, Karen Sweiss, Pritesh Patel, Sally Campbell-Lee, Nadim Mahmud, Victor R. Gordeuk, Damiano Rondelli, Santosh L. Saraf

Blood (2022) 140 (Supplement 1): 4747–4748.

https://doi.org/10.1182/blood-2022-160050

Published: 2022

Journal Articles

Isoform Selective HDAC8 Inhibitor (OCH3) Shows Potency in Selectively Targeting Primary AML Cells

Amal Mechaal, Amudha Ganapathy, Dolores Mahmud, Taha Y Taha, Rajeev Ranjan, Irum Khan, Pavel Petukhov, Nadim Mahmud

Blood (2021) 138 (Supplement 1): 2944.

https://doi.org/10.1182/blood-2021-151599

Published: 2021

Journal Articles

Monitoring of Stored Hematopoietic Stem/Progenitor Graft Stability Program in a Single Institute

Youngmin Park, MS, Grace Irene, BS, Amudha Ganapathy, PhD, Dolores Mahmud, PhD, Pritesh Patel, MB, ChB, Damiano Rondelli, MD, Nadim Mahmud, MBBS, PhD

Blood (2019) 134 (Supplement_1): 1968.

https://doi.org/10.1182/blood-2019-132145

Published: 2019

Journal Articles

Development of a Real Time Pharmacokinetic Testing Method to Allow for Targeted Melphalan Dosing in Multiple Myeloma Patients Undergoing Autologous Transplant

Karen Sweiss, PharmD, Bhaskar Vemu, PhD, Gregory Sampang Calip, PharmD,MPH,PhD, John P Galvin, MDMS,MPH, John G. Quigley, Nadim Mahmud, MBBS, PhD, Damiano Rondelli, MD, Jeremy Johnson, PharmD, PhD, Pritesh Patel, MB, ChB

Blood (2019) 134 (Supplement_1): 3310.

https://doi.org/10.1182/blood-2019-132216

Published: 2019

Journal Articles

A New Prognostic Score Using Lymphocyte to Monocyte Ratio and Immunoglobulin Levels to Predict Progression in Multiple Myeloma Patients Undergoing Autologous Transplant

Karen Sweiss, PharmD, Gregory Sampang Calip, PharmD, MPH, PhD, Jonathan Lee, Nadim Mahmud, MBBS, PhD, Damiano Rondelli, MD, Pritesh Patel, MD

Blood (2018) 132 (Supplement 1): 3442.

https://doi.org/10.1182/blood-2018-99-118965

Published: 2018

Journal Articles

PARP Inhibitor Veliparib and Busulfan in a Xenograft Model of Myeloproliferative Neoplasm

Pritesh Patel, MD, Vitalyi Senyuk, PhD, Natalie S. Rodriguez, MS, Dolores Mahmud, PhD, Annie Lee Oh, MD, Nadim Mahmud, MBBS, PhD, Giovanni Barosi, MD, Damiano Rondelli, MD

Blood (2018) 132 (Supplement 1): 3319.

https://doi.org/10.1182/blood-2018-99-119497

Published: 2018

Journal Articles

Validation of FOXM1 As a Therapeutic Target in Acute Myeloid Leukemia

Irum Khan, MBBS, Anand Ashwin Patel, MD, Marianna Halasi, Rachael Schultz, BA, Yi-Hua Chen, MD, Nathan Aardsma, DO, Nandini Kalakota, MD, Li C Liu, PhD, Nadim Mahmud, MBBS, PhD, Peter Gann, MD, Olga Frankfurt, MD, Andrei Gartel, PhD

Blood (2017) 130 (Supplement 1): 300.

https://doi.org/10.1182/blood.V130.Suppl_1.300.300

Published: 2017

Journal Articles

Chronic Myeloid Leukemia in Chronic Phase As an Adrenal Tumor Masquerading As a Myelolipoma

John G. Quigley, MD, Basharath Khan, MD, Nandini Kalakota, MD, Nathan Aardsma, DO, Nadim Mahmud, MBBS, PhD

Blood (2017) 130 (Supplement 1): 5259.

https://doi.org/10.1182/blood.V130.Suppl_1.5259.5259

Published: 2017

Journal Articles

Combined Immune Score of Lymphocyte to Monocyte Ratio and Immunoglobulin Levels Predicts Progression-Free Survival of Myeloma Patients after Autologous Transplant

Karen Sweiss, PharmD, Jonathan Lee, Annie L. Oh, MD, Gregory Sampang Calip, PharmD,MPH,PhD, Nadim Mahmud, MBBS, PhD, Damiano Rondelli, MD, Pritesh Patel, MB, CHB

Blood (2017) 130 (Supplement 1): 2012.

https://doi.org/10.1182/blood.V130.Suppl_1.2012.2012

Published: 2017

Journal Articles

Generation of Megakaryocytes and Platelets from Valproic Acid Expanded Human Cord Blood CD34+ Cells in Culture

Nadim Mahmud, MBBS, PhD, Rajeev Ranjan, PhD, Jia J. Wu, BS, Benjamin Petro, Meryem K. Terzioglu, MD, Hasan Issa, MBBch, Darryl A. Abbott, BS, Dolores Mahmud, PhD, William M. Miller, PhD

Blood (2017) 130 (Supplement 1): 3751.

https://doi.org/10.1182/blood.V130.Suppl_1.3751.3751

Published: 2017

Journal Articles

Stable Engraftment with Haploidentical Peripheral Blood Stem Cell Transplantation in Adult Patients with Sickle Cell Disease

Santosh L. Saraf, MD, Pritesh Patel, MB, CHB, Karen Sweiss, PharmD, Oh Annie, MD, Matthew Koshy, MD, Sally Campbell-lee, MD, Michel Gowhari, DO, Shivi Jain, MD, David Peace, MD, John G. Quigley, MD, Irum Khan, MBBS, Robert E. Molokie, MD, Nadim Mahmud, MBBS, PhD, Victor R. Gordeuk, MD, Damiano Rondelli, MD

Blood (2017) 130 (Supplement 1): 4591.

https://doi.org/10.1182/blood.V130.Suppl_1.4591.4591

Published: 2017

Journal Articles

Gaussian Mixture Models and Machine Learning Predict Megakaryocytic Growth and Differentiation Potential Ex Vivo

Jia J. Wu, BS, Darryl A. Abbott, BS, Meryem K. Terzioglu, MD, Dolores Mahmud, PhD, Nadim Mahmud, MBBS, PhD, William M. Miller, PhD, Neda Bagheri, PhD

Blood (2017) 130 (Supplement 1): 4474.

https://doi.org/10.1182/blood.V130.Suppl_1.4474.4474

Published: 2017

NARROW

Feasibility and Target AUC Accuracy of Personalized High Dose Melphalan in Myeloma

Haploidentical Peripheral Blood Stem Cell Transplantation in 20 Adult Patients with Sickle Cell Disease

VPA Expanded CD34+CD90+ Cells Despite Having Identical Phenotype Are Functionally Distinct Based on Their Origin

Graft CD34+ Cell Dosing Adjustment Based on Body Surface Area As a Better Predictor of Hematopoietic Engraftment

Retention of In Vivo Functional Potential of Cryopreserved Human HSPC Grafts after 10 Years

Addition of Myeloablative Doses of Total Marrow Irradiation (TMI) to Myeloablative Fludarabine/Busulfan Conditioning for Allogeneic HSCT in Patients with High-Risk AML, CML, or Myelodysplastic Syndrome: A Phase II Clinical Trial

Long-Term Adverse Events of Total Marrow Irradiation (TMI)-Based Conditioning Chemotherapy in Hematopoietic Stem Cell Transplant Recipients Treated on a Phase I/II Trial

Safety and Efficacy of the Addition of the Protein Translation Inhibitor Omacetaxine to Induction with Cytarabine and Idarubicin in Newly Diagnosed AML

G-CSF Improves Stable Engraftment in Adults with Sickle Cell Disease Undergoing Nonmyeloablative Hematopoietic Stem Cell Transplantation

Isoform Selective HDAC8 Inhibitor (OCH3) Shows Potency in Selectively Targeting Primary AML Cells

Monitoring of Stored Hematopoietic Stem/Progenitor Graft Stability Program in a Single Institute

Development of a Real Time Pharmacokinetic Testing Method to Allow for Targeted Melphalan Dosing in Multiple Myeloma Patients Undergoing Autologous Transplant

A New Prognostic Score Using Lymphocyte to Monocyte Ratio and Immunoglobulin Levels to Predict Progression in Multiple Myeloma Patients Undergoing Autologous Transplant

PARP Inhibitor Veliparib and Busulfan in a Xenograft Model of Myeloproliferative Neoplasm

Validation of FOXM1 As a Therapeutic Target in Acute Myeloid Leukemia

Chronic Myeloid Leukemia in Chronic Phase As an Adrenal Tumor Masquerading As a Myelolipoma

Combined Immune Score of Lymphocyte to Monocyte Ratio and Immunoglobulin Levels Predicts Progression-Free Survival of Myeloma Patients after Autologous Transplant

Generation of Megakaryocytes and Platelets from Valproic Acid Expanded Human Cord Blood CD34+ Cells in Culture

Stable Engraftment with Haploidentical Peripheral Blood Stem Cell Transplantation in Adult Patients with Sickle Cell Disease

Gaussian Mixture Models and Machine Learning Predict Megakaryocytic Growth and Differentiation Potential Ex Vivo

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only